RaDVaC Data Explorer
Antiviral database
Virus Taxonomy
← Back to Dashboard
Docosanol
Inhibition of fusion
2D Structure
Could not render structure
View on PubChem
3D Structure
Loading 3D structure...
Chemical Identifiers
SMILES:
CCCCCCCCCCCCCCCCCCCCCCO
InChI Key:
NOPFSRXAKWQILS-UHFFFAOYSA-N
ClinicalTrials.gov
PubMed
Clinical Development by Virus
8
Herpes simplex virus (HSV)
HSV
Target: Envelope proteins
FDA approved
Preclinical
Phase 2
positive
Phase 3
positive
Approved
FDA
Approval ref: AntiviralDb
Human alphaherpesvirus 1
HSV-1
Target: Viral glycoprotein
FDA approved
Preclinical
Phase 2
positive
Phase 3
positive
Approved
FDA
DB00194
Human alphaherpesvirus 2
HSV-2
Target: Viral glycoprotein
FDA approved
Preclinical
Phase 2
positive
Phase 3
positive
Approved
FDA
PMID:1660151
Human gammaherpesvirus 8
KSHV
Target: Viral glycoprotein
Phase 2
Preclinical
Phase 2
Phase 3
Approved
PMID:11177381
Human immunodeficiency virus 1
HIV-1
Target: Viral glycoprotein
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:8825621
Human orthopneumovirus
RSV
Target: Viral glycoprotein
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:1660151
Human betaherpesvirus 5
CMV
Target: Viral glycoprotein
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:11177381
Human betaherpesvirus 6
HHV-6
Target: Viral glycoprotein
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:11177381